Fairvalue-Calculator Fairvalue-Calculator
EN DE

OPTUS Pharmaceutical Co (131030) Fair Value & Analysis

Healthcare · KR · Market cap 103B KRW

Price5,760 KRW
Fair Value12,160 KRW
Upside+111.1%
Quality95/100
Evidence: High Range 9,120 KRW – 15,200 KRW

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

OPTUS Pharmaceutical Co (131030) currently trades at 5,760 KRW, while our model-based Fair Value estimate is 12,160 KRW — implying the stock looks roughly 111.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company was formerly known as DHP Korea Co., Ltd. OPTUS Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Cheongju, South Korea.

Open the full interactive analysis →

Similar stocks

Takeda Pharmaceutical Company (TAKP34) +3193% Jiangsu Hengrui Pharmaceuticals Co (600276) -37% Sun Pharmaceutical Industries Limited (SUNPHARMA) -44% Zoetis Inc (Z1TS34) -1% Hansoh Pharmaceutical Group (3692) -37% Divi's Laboratories Limited (DIVISLAB) -70%

Frequently asked questions

Is OPTUS Pharmaceutical Co (131030) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 12,160 KRW versus a price of 5,760 KRW — about +111% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 131030?
Our 21-model fair value for OPTUS Pharmaceutical Co is 12,160 KRW (as of Jun 25, 2026), built from audited fundamentals. The current price is 5,760 KRW.
What is the quality score of 131030?
OPTUS Pharmaceutical Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.